Veterinary immunology is a specialized field focused on understanding the immune system of animals, emphasizing the prevention and control of infectious diseases in veterinary medicine. The immune responses in animals, similar to those in humans, involve intricate interactions between various cells, tissues, and molecules. Research in veterinary immunology addresses the development of vaccines, diagnostics, and immunotherapies to protect animals from a wide range of pathogens. This includes viruses, bacteria, parasites, and fungi that can cause diseases in livestock, pets, and wildlife. Vaccination plays a pivotal role in veterinary immunology, preventing diseases like canine distemper, feline leukemia, and foot-and-mouth disease in livestock. Advancements in adjuvant technologies, delivery systems, and recombinant DNA techniques contribute to the development of effective and safe veterinary vaccines. Understanding the principles of veterinary immunology is essential for maintaining animal health, ensuring food safety, and mitigating the impact of zoonotic diseases that can be transmitted between animals and humans. Ongoing research in veterinary immunology continues to improve our ability to safeguard the health and well-being of diverse animal populations.
Title : The importance of post-marketing surveillance and real-world data: For a product to be successful
Regina Au, BioMarketing Insight, United States
Title : A promising novel approach to DNA vaccines
Khursheed Anwer, IMUNON, United States
Title : Prophylactic and molecular approaches for mitigating human influenza A viruses: i. Evaluating influenza vaccine effectiveness in the older population ii. Down-regulation of influenza virus genes with novel sirna-chimeric-ribozyme constructs
Madhu Khanna, University of Delhi, India
Title : Post COVID-19 syndrome is associated with sex and severity of first COVID-19 episode in Honduras
Manuel Antonio Sierra Santos, Central American Technological University, Honduras
Title : Homology analysis of MPXV and VACV peptides underscores the need to consider both MPXV clades for vaccine development
Lara Isis Teodoro, Mayo Clinic, United States
Title : Establishing a platform method for physical appearance assessment of new parenteral pharmaceuticals
Ying Wan, Merck & Co., United States
Title : Development of a novel multi-component vaccine to address the burden of otitis media in high-risk populations
Ayesha Zahid, Griffith University, Australia
Title : High seroprevalence of RSV antibodies in adults indicates potential undetected transmission and requires further public health assessment
Lara Isis Teodoro, Mayo Clinic, United States
Title : New biomarkers in leishmania major vaccine development
Negar Seyed, Pasteur Institute of Iran, Iran (Islamic Republic of)
Title : Development of a platform UPLC-CAD method for high-throughput lipid quantitation and characterization in novel mRNA LNPs
Janet Muzulu, Sanofi, United States